GRAIL, Inc. $GRAL Stock Holdings Lifted by Aberdeen Group plc

Key Points

• Aberdeen Group plc increased its stake in GRAIL, Inc. by 34.9%, now owning 284,735 shares valued at approximately $7.27 million.
• Insider Chun R. Ding sold 339,800 shares for over $16.8 million, which represented a 9.32% decrease in their holdings.
• Analyst firm Canaccord Genuity raised GRAIL's price target from $32.00 to $43.00, maintaining a "buy" rating amidst a current consensus rating of "hold."

Aberdeen Group plc boosted its holdings in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 34.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 284,735 shares of the company's stock after acquiring an additional 73,667 shares during the quarter. Aberdeen Group plc owned about 0.81% of GRAIL worth $7,272,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GRAL. State of Tennessee Department of Treasury acquired a new stake in shares of GRAIL during the fourth quarter worth $28,000. Caldwell Sutter Capital Inc. acquired a new stake in shares of GRAIL during the first quarter worth $28,000. Sterling Capital Management LLC acquired a new stake in shares of GRAIL during the fourth quarter worth $29,000. KBC Group NV raised its position in shares of GRAIL by 187.7% during the first quarter. KBC Group NV now owns 1,430 shares of the company's stock worth $37,000 after purchasing an additional 933 shares during the period. Finally, S.A. Mason LLC raised its position in shares of GRAIL by 50.1% during the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after purchasing an additional 500 shares during the period.

GRAIL Stock Performance

Shares of GRAL stock traded up $1.09 on Friday, reaching $34.24. 637,832 shares of the company's stock traded hands, compared to its average volume of 879,593. GRAIL, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The business's 50 day moving average price is $39.21 and its two-hundred day moving average price is $36.37.

GRAIL (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. The business had revenue of $35.54 million for the quarter, compared to analysts' expectations of $37.57 million. On average, sell-side analysts predict that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Activity

In other news, major shareholder Chun R. Ding sold 339,800 shares of GRAIL stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total transaction of $16,830,294.00. Following the transaction, the insider owned 3,305,055 shares in the company, valued at approximately $163,699,374.15. The trade was a 9.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 9,692 shares of GRAIL stock in a transaction on Monday, June 30th. The shares were sold at an average price of $52.00, for a total value of $503,984.00. Following the transaction, the president owned 492,076 shares in the company, valued at $25,587,952. This represents a 1.93% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 361,694 shares of company stock worth $17,780,266. 1.85% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group boosted their target price on GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, GRAIL presently has a consensus rating of "Hold" and an average target price of $31.50.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.